A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck. | Cancer;92(2): 326-31, 2001 Jul 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck.

Colevas, A D; Amrein, P C; Gomolin, H; Barton, J J; Read, R R; Adak, S; Benner, S; Costello, R; Posner, M R.

Affiliation

Colevas AD; Head and Neck Oncology Program, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. alexander_colevas@dcfi.harvard.edu

Cancer ; 92(2): 326-31, 2001 Jul 15.

Article in En | MEDLINE | ID: mdl-11466686

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Head and Neck Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Head and Neck Neoplasms Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2001 Document type: Article Affiliation country: Country of publication: